Elsevier

Neuropharmacology

Volume 34, Issue 2, February 1995, Pages 141-147
Neuropharmacology

General paper
1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices

https://doi.org/10.1016/0028-3908(94)00128-FGet rights and content

Abstract

It is now clear that the AMPA subtype of ionotropic glutamate receptors (iGluRs) undergoes a rapid desensitization in response to activation by AMPA receptor agonists. This desensitization is inhibited by compounds such as aniracetam and cyclothiazide, which act at a distinct site on the AMPA receptor complex. In particular, cyclothiazide greatly potentiates AMPA receptor-mediated depolarizing responses in the hippocampus. We have recently shown cyclothiazide also increases AMPA-induced release of [3H]norepinephrine ([3H]NE). More, recently, a benzamide compound, 1-(1,3-benzodioxol-5-ylcarbonyl)-piperidine (1-BCP), has been reported to enhance AMPA-induced currents and to facilitate memory retention in rats in a number of memory tasks. In this study, the effects of 1-BCP on excitatory amino acid agonist-induced [3H]NE release in rat hippocampal slices were determined. We report that 1-BCP, like cyclothiazide, selectively potentiates AMPA-induced [3H]NE release. However, cyclothiazide was more potent and efficacious than 1-BCP. Nevertheless, these data suggest a role for AMPA receptor-mediated enhancement of norepinephrine release as a mechanism of action for nootropic compounds such as 1-BCP.

References (37)

  • C.F. Zorumski et al.

    A benzodiazepine recognition site associated with the non-NMDA glutamate receptor

    Neuron

    (1993)
  • M. Bertolino et al.

    Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus

    Receptors and Channels

    (1993)
  • R. Cumin et al.

    Effects of the novel compound aniracetam (Ro 13–5057) upon impaired learning and memory in rodents

    Psychopharmacology

    (1982)
  • D. Dahl et al.

    Norepinephrine induces pathway-specific long-lasting potentiation and depression in the hippocampal dentate gyrus

  • M.A. Desai et al.

    Cyclothiazide selectively potentiates AMPA- and kainate- induced [3H]norepinephrine release from rat hippocampal slices

    J. Neurochem.

    (1994)
  • M.A. Desai et al.

    Cyclothiazide acts at a site on the AMPA receptor complex that does not recognize competitive or non-competitive AMPA receptor antagonists

    J. Pharmac. Exp. Ther.

    (1995)
  • K. Fink et al.

    Veratridine and other depolarizing agents counteract the inhibitory effect of Mg2+ ions on N-methyl-D-aspartate (NMDA)-induced noradrenaline release in vitro

    Naunyn-Schmiedeberg's Archs Pharmac.

    (1990)
  • R. Granger et al.

    A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task

    Synapse

    (1993)
  • Cited by (26)

    • Norepinephrine and the dentate gyrus

      2007, Progress in Brain Research
      Citation Excerpt :

      Finally, cognitive enhancers significantly facilitate NE release in response to glutamate, even in the presence of the endogenous NMDA receptor antagonist, kynurenate (Pittaluga et al., 1997). This facilitation is suggested to be an important mediator of cognitive enhancement (Desai et al., 1995; Pittaluga et al., 2001). Conversely, NE enhances glutamate release in DG, an effect which depends on presynaptic β adrenoceptors (Lynch and Bliss, 1986).

    View all citing articles on Scopus
    View full text